OBJECTIVES: Nongastrointestinal (non-GI) somatic complaints are common in children and adults with functional gastrointestinal disorders (FGIDs). The aim of the present study was to determine whether non-GI somatic complaints in children with functional abdominal pain (FAP) were associated with FGIDs in adolescence and young adulthood. PATIENTS AND METHODS: In a prospective clinic-based study, children and adolescents (ages 8-16 years) with FAP (n = 188) and well controls (n = 61) completed a validated measure of somatic symptoms. Participants were assessed 4 to 15 years later (as older adolescents and young adults) for presence of current FGIDs as defined by the Rome III criteria. RESULTS: Of the 188 youths with pediatric FAP, 35.6% met criteria for FGIDs at follow-up. Initial levels of non-GI somatic symptoms were significantly higher in pediatric FAP participants who subsequently met criteria for FGIDs at follow-up compared with controls and pediatric FAP participants who did not meet criteria for FGIDs at follow-up. CONCLUSIONS: The association of non-GI somatic symptoms with FAP in children may identify a group that is at risk for FGIDs later in life.
OBJECTIVES: Nongastrointestinal (non-GI) somatic complaints are common in children and adults with functional gastrointestinal disorders (FGIDs). The aim of the present study was to determine whether non-GI somatic complaints in children with functional abdominal pain (FAP) were associated with FGIDs in adolescence and young adulthood. PATIENTS AND METHODS: In a prospective clinic-based study, children and adolescents (ages 8-16 years) with FAP (n = 188) and well controls (n = 61) completed a validated measure of somatic symptoms. Participants were assessed 4 to 15 years later (as older adolescents and young adults) for presence of current FGIDs as defined by the Rome III criteria. RESULTS: Of the 188 youths with pediatric FAP, 35.6% met criteria for FGIDs at follow-up. Initial levels of non-GI somatic symptoms were significantly higher in pediatric FAPparticipants who subsequently met criteria for FGIDs at follow-up compared with controls and pediatric FAPparticipants who did not meet criteria for FGIDs at follow-up. CONCLUSIONS: The association of non-GI somatic symptoms with FAP in children may identify a group that is at risk for FGIDs later in life.
Authors: Andrée Rasquin; Carlo Di Lorenzo; David Forbes; Ernesto Guiraldes; Jeffrey S Hyams; Annamaria Staiano; Lynn S Walker Journal: Gastroenterology Date: 2006-04 Impact factor: 22.682
Authors: Antoinette Y Konijnenberg; Elisabeth R de Graeff-Meeder; Joost van der Hoeven; Jan L L Kimpen; Jan K Buitelaar; Cuno S P M Uiterwaal Journal: Pediatrics Date: 2006-03 Impact factor: 7.124
Authors: John M Rosen; Jose T Cocjin; Jennifer V Schurman; Jennifer M Colombo; Craig A Friesen Journal: World J Gastrointest Pharmacol Ther Date: 2014-08-06
Authors: Leo A A Spee; Yvonne Lisman-van Leeuwen; Marc A Benninga; Sita M A Bierma-Zeinstra; Boudewijn J Kollen; Marjolein Y Berger Journal: Ann Fam Med Date: 2015-03 Impact factor: 5.166
Authors: Amanda L Stone; Lynn S Walker; Lauren C Heathcote; J Maya Hernandez; Molly C Basch; Anna C Wilson; Laura E Simons Journal: J Pain Date: 2019-02-13 Impact factor: 5.820
Authors: Rona L Levy; Shelby L Langer; Joan M Romano; Jennifer Labus; Lynn S Walker; Tasha B Murphy; Miranda A L van Tilburg; Lauren D Feld; Dennis L Christie; William E Whitehead Journal: Clin J Pain Date: 2014-12 Impact factor: 3.442